ClinicalTrials.gg
RecruitingNCT06331338Updated Feb 12, 2025

Effects of Using Decision Cycle for Person-Centered Glycemic Management in Type 2 Diabetes

An interventional study of Decision Cycle for Person-Centered Glycemic Management and Traditional diabetes self-management education in Type 2 Diabetes, sponsored by National Taiwan University Hospital. Recruiting at 1 site in Taiwan. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2025-02-12.

Sponsored by National Taiwan University Hospital · Not applicable, Interventional, and Other

How we know

From the registry’s dates

  • Primary completion was expected by Oct 2025, 1 year ago, but the record still lists the study as recruiting.
  • Started Feb 2024; still recruiting 2 years 9 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
130
Allocation
Non-randomized
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 17 studies in Diabetes Mellitus, Type 2 by National Taiwan University Hospital — 9 open to participants now, 9 under way, none of them phase 3. Diabetes Mellitus, Type 2 · National Taiwan University Hospital.

Started
2024
with 1 other
No phase
8 of 17
5 open now
Registered
11th of 17
by date

Among the 17 studies in Diabetes Mellitus, Type 2 by National Taiwan University Hospital, this one is one of 2 that started in 2024, is one of 8 with no phase, and was the 11th registered.

Diabetes Mellitus, Type 2

10,403 studies on the registry are indexed under Diabetes Mellitus, Type 2; 1,413 are open to participants now.

Browse Diabetes Mellitus, Type 2 studies →

Open to participants now

9 of the 17 studies in Diabetes Mellitus, Type 2 by National Taiwan University Hospital are open now, in 1 country. Recruiting first, the newest first:

3 more — sign in →

By country, each count listing its studies:

All 9 open studies →

Where they have run

Who these studies take

Of the 882 Diabetes Mellitus, Type 2 studies recruiting now, 372 (42%) set no upper age limit and 384 (44%) stop at 75 or younger; 52 take children under 18; 202 take healthy volunteers.

This study: 18 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 17 studies in Diabetes Mellitus, Type 2 by National Taiwan University Hospital, or all of them as a file.
02

Study summary

Decision cycle for person-centered glycemic management is a new diabetes decision making .It is defined as a purposefully designed holistic care intervention .The goal is to improve the self-care behavior of patients with type 2 diabetes, thereby improving glycated hemoglobin levels and delaying the occurrence of complications.

Read the detailed description

The "Decision Cycle for Person-Centered Glycemic management" jointly proposed by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) in 2018 , which develops treatment goals and plans based on the patient's personal preferences, values, and goals.

Participants will be divided into two groups(treatment group 、control group).Treatment group will accept the "Decision Cycle for Person-Centered Glycemic Management " .It is a person-centered diabetes decision making. Control group will accept the traditional diabetes self-management education. It content focuses more on teaching relevant knowledge and some skills.It is a educator-centered approach.

Baseline / pre-intervention test (after signing informed consent form) post-intervention test (after finishing intervention) Researchers will compare treatment group and control group to see if treatment group has better performance on self-care Behaviors and glycated hemoglobin levels .

03

Conditions studied

  • Type 2 Diabetes

Keywords

  • Decision Cycle for Person-Centered Glycemic Management
  • Self-Care Behaviors
  • Type 2 Diabetes
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. Patients diagnosed with type 2 diabetes by a physician.
  2. Age: 18 years or above.
  3. (HbA1c ) test value: 7.5-9.0 %
  4. No diabetic oral medications, insulin and glucagon-like peptide-1 were replaced in the outpatient when the case was admitted.
  5. No pregnancy during the study period.
  6. After the researcher explains the purpose of the research, the research subjects agree to join this researcher.
  7. Those who are conscious and able to take care of themselves.
  8. There is no diagnostic certificate from the American Psychiatric Association's Diagnostic Manual of Mental Disorders, Fourth Edition ()of all mental illnesses.
  9. Those who can communicate in Mandarin and Taiwanese.

Exclusion criteria

Exclusion Criteria:

  1. Patients diagnosed with type 1 diabetes by a physician.
  2. Age: Under 18 years old.
  3. test value: less than 7.5 % and greater than 9.0 %
  4. Those who replaced oral diabetes medications, insulin and glucagon-like peptide- 1 at the outpatient at the time of admission.
  5. Pregnancy during the study period.
  6. Those who are unable to take care of themselves and express themselves.
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

HbA1c

A blood test of average blood sugar over the past two to three months, given as a percentage or in mmol/mol. 6.5% (48 mmol/mol) or more is the usual threshold for diabetes, normally confirmed by a second test.

DSM diagnostic criteria

The American Psychiatric Association’s manual of mental health diagnoses. DSM-5 (2013, revised as DSM-5-TR in 2022) replaced DSM-IV, and some studies still name the older edition. “Meets DSM criteria for …” means diagnosed by that edition’s diagnostic criteria, usually by a clinician in an interview.

05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Non-randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
130 participants (estimated)

Study arms

  • Experimental
    New health education:use [Decision Cycle for Person-Centered Glycemic Management ]

    It is a person-centered approach to care. Treatment goals and plans should be cotreated with people with diabetes based on their individual preferences, values, and goals.

    Behavioral: Decision Cycle for Person-Centered Glycemic Management

  • Active comparator
    Traditional diabetes self-management education

    It is a educator-centered approach to care.

    Other: Traditional diabetes self-management education

Interventions

  • BehavioralDecision Cycle for Person-Centered Glycemic Management

    It is defined as a purposefully designed holistic care intervention that improve self-management .

  • OtherTraditional diabetes self-management education

    Traditional diabetes self-management education content focuses more on teaching relevant knowledge and some skills.

06

What researchers measure

Primary outcomes

  1. glycemic control (HbA1c)

    The HbA1c level is a marker of the average blood glucose levels over a period of the last 2-3 months.

    Time frame: Before the task and 3 months post intervention

Secondary outcomes

  1. Diabetes Self-Care Behavior Scale

    It is contains 20 likert-scaled (1-5) items, it assessed the frequency with which patients performed the diabetes self-care behaviors, including how often took diabetes medications, exercise, blood glucose monitor, diet . A higher score indicates greater self care behavior .

    Time frame: Before the task and 3 months post intervention

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Feb 2024 (actual). Primary completion is estimated for Oct 2025, 20 months after the start.

Of 2,078 non-industry interventional studies with no phase under Diabetes Mellitus, Type 2, half reached primary completion within 21 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 40. This study's planned 20 months is close to that.

Counting every sponsor, half of 2,255 studies reached it within 21 months; a quarter within 10 and three quarters within 39.

How these figures are worked out, and which studies are left out of them.

Registered
Mar 20, 2024
First posted
Mar 26, 2024
StartActual
Feb 14, 2024
Primary completionEst.
Oct 31, 2025
CompletionEst.
Dec 31, 2025
Last update
Feb 12, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Feb 12, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06331338
Responsible party
Sponsor
First posted
Mar 26, 2024
Start date
Feb 14, 2024
Primary completion
Oct 31, 2025 (estimated)
Completion
Dec 31, 2025 (estimated)
Last update
Feb 12, 2025

Study contacts

Chia-Hui Tsai
Contact
mtsai0322@gmail.com
886926124093
Kang-Chih Fan
Contact
ntuhendocrine@gmail.com
886972654308
Kang-Chih Fan
principal investigator · National Taiwan University

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion